Paul S. Martin, MD

Physician
Seattle Cancer Care Alliance
Clinical Assistant Professor, Division of Oncology
University of Washington School of Medicine
Specialty:
Medical Oncology
“I believe that honest, straightforward communication is key to providing compassionate, comprehensive and highly personalized care. I strive to learn from, educate and collaborate with all my patients.”
— Paul S. Martin, MD
What do you enjoy about working with patients who have blood diseases?

Throughout my medical career, I have been inspired by the strength and resilience of oncology and hematology patients. I learn from my patients on a daily basis how to negotiate the balance between what we can control in life and what we can’t. The most rewarding aspect of my job is the unique bond that comes from working with patients and their family members during what is often one of the most challenging times of their lives.

Paul S. Martin, MD
How do you like to work with patients?

I believe that honest, straightforward communication is key to providing compassionate, comprehensive and highly personalized care. I strive to learn from, educate and collaborate with you in order to mutually formulate treatment plans that incorporate not only the most relevant and up-to-date medical evidence, but also your individual goals and preferences. Rather than always leading the discussion, I often prefer to facilitate it, so that you feel empowered to share what’s important to you.

Provider background

Specialty: Medical Oncology

Blood cancers and non-malignant blood disorders

I am a board-certified hematologist-oncologist with SCCA who provides care at  UW Medicine’s Northwest Hospital & Medical Center. I specialize in treating patients with hematological malignancies, such as lymphoma, as well as other blood disorders. In addition to working directly with patients, I also help coordinate clinical trials at Northwest Hospital in order to offer the most cutting-edge therapies to our patients. My own research interests include exploring novel therapies for hematological malignancies and more personalized, precise treatment options.

Benign Not cancer. Benign tumors may grow larger but do not spread to other parts of the body. Hematologist A physician who specializes in diseases of the blood and blood-forming tissues. Lymphoma Cancer that begins in the cells of the immune system. There are two basic categories of lymphomas: Hodgkin lymphoma and non-Hodgkin lymphomas. Cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.

Diseases treated

Education, experience and certifications
Medical Degree
University of Washington School of Medicine
Residency
Brigham and Women's Hospital
Fellowship
Fred Hutchinson Cancer Research Center, University of Washington Hematology-Oncology Fellowship Program
Board Certification
Medical Oncology, 2016, American Board of Internal Medicine; Hematology, 2016, American Board of Internal Medicine; Internal Medicine, 2013, American Board of Internal Medicine
Languages
English

Research

Clinical trials

We make promising new treatments available to you through studies called clinical trials led by SCCA doctors. Many of these trials at SCCA have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.

Study ID:
NCT04799275
Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma
Complete title
A PHASE II/III RANDOMIZED STUDY OF R-MINICHOP WITH OR WITHOUT CC-486 (ORAL AZACITIDINE) IN PARTICIPANTS AGE 75 YEARS OR OLDER WITH NEWLY DIAGNOSED DIFFUSE LARGE B CELL LYMPHOMA, GRADE IIIB FOLLICULAR LYMPHOMA, TRANSFORMED LYMPHOMA, AND HIGH-GRADE B-CELL LYMPHOMAS WITH MYC AND BCL2 AND/OR BCL6 REARRANGEMENTS

Publications

Many of our SCCA physicians conduct ongoing research to improve standards of patient care. Their work is evaluated by other physicians and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this SCCA provider has written.

Your care team

At SCCA, you receive care from a team of providers with extensive experience in your disease. Your team includes doctors, a team coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like nutritionists, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.
Registered nurse (RN)
Registered nurse (RN)
Your nurse manages your care alongside your physician and assists with care procedures and treatments.
Patient care coordinator
Patient care coordinator
Your patient care coordinator works closely with you and your physician and serves as your scheduler.

Insurance

SCCA accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.

For providers